Data gathered: June 18
AI Stock Analysis - Resmed (RMD)
Analysis generated June 18, 2025. Powered by Chat GPT.
ResMed Inc. (RMD) specializes in the development, manufacturing, and marketing of products for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. ResMed operates globally, with its comprehensive portfolio including devices, cloud-connected software applications, and other healthcare solutions aimed at managing chronic diseases more effectively and economically. ResMed's mission is to improve patients' quality of life, reduce the impact of chronic disease, and innovate at the intersection of medical devices and digital health.
Stock Alerts - Resmed (RMD)
 |
Resmed | June 14 Employee Rating is up by 2.4% over the last month. |
|
Resmed | June 11 Insider Alert: Farrell Michael J. is selling shares |
|
Resmed | June 10 Web Traffic is up by 36.4% over the last month. |
|
Resmed | June 7 Insider Alert: FARRELL PETER C is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Resmed
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 343 | Sign up | Sign up | Sign up |
| Sentiment | 63 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,755,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 88 | Sign up | Sign up | Sign up |
| Patents | 840 | Sign up | Sign up | Sign up |
| 4chan Mentions | 1 | Sign up | Sign up | Sign up |
| Facebook Engagement | 413 | Sign up | Sign up | Sign up |
| Facebook Followers | 166,354 | Sign up | Sign up | Sign up |
| Instagram Followers | 7,980 | Sign up | Sign up | Sign up |
| Reddit Mentions | 10 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,666 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,568 | Sign up | Sign up | Sign up |
| Twitter Mentions | 24 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 51,700 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 76 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,233 | Sign up | Sign up | Sign up |
About Resmed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Price | $252.50 |
| Target Price | Sign up |
| Volume | 82,460 |
| Market Cap | $36.9B |
| Year Range | $204.1 - $256.52 |
| Dividend Yield | 0.85% |
| PE Ratio | 28.03 |
| Analyst Rating | 50% buy |
| Industry | Medical Devices |
In the news
 |
SG Americas Securities LLC Has $1.07 Million Position in ResMed Inc. (NYSE:RMD)June 18 - ETF Daily News |
 |
Resmed AirSense 11 Autoset Device 4G with Mask from $1510.50 Delivered @ CPAP DirectJune 17 - Ozbargain.com.au |
|
Ritholtz Wealth Management Buys 7,582 Shares of ResMed Inc. (NYSE:RMD)June 17 - ETF Daily News |
|
Assenagon Asset Management S.A. Has $2.44 Million Holdings in ResMed Inc. (NYSE:RMD)June 17 - ETF Daily News |
 |
ResMed Stock: Is RMD Outperforming the Healthcare Sector?June 16 - Biztoc.com |
|
CVA Family Office LLC Acquires 48 Shares of ResMed Inc. (NYSE:RMD)June 16 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 1.29B | 525M | 766M | 365M | 426M | 2.370 |
| Q4 '24 | 1.28B | 531M | 751M | 345M | 362M | 2.430 |
| Q3 '24 | 1.22B | 507M | 717M | 311M | 443M | 2.200 |
| Q2 '24 | 1.22B | 519M | 704M | 292M | 422M | 2.080 |
| Q1 '24 | 1.2B | 515M | 682M | 300M | 429M | 2.130 |
Insider Transactions View All
| Farrell Michael J. filed to sell 455,503 shares at $251.2. June 10 '25 |
| FARRELL PETER C filed to sell 69,218 shares at $247.3. June 6 '25 |
| Rider Michael J filed to sell 8,870 shares at $243.8. June 3 '25 |
| Sandercock Brett filed to sell 85,283 shares at $243.8. June 3 '25 |
| Sandercock Brett filed to sell 86,283 shares at $244.6. May 27 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$101.62 0.1% | 51 |
 |
Edwards LifesciencesEW |
$73.7 0.6% | 29 |
 |
Intuitive SurgicalISRG |
$512.35 0% | 61 |
 |
MedtronicMDT |
$86.2 0% | 62 |
 |
StrykerSYK |
$375.27 0.5% | 41 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kelly Morrison |
May 14, 25 | Sell | $1K - $15K |
| Kelly Louise Morrison |
May 14, 25 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
Read more about Resmed (RMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Resmed?
The Market Cap of Resmed is $36.9B.
What is Resmed's PE Ratio?
As of today, Resmed's PE (Price to Earnings) ratio is 28.03.
What is the current stock price of Resmed?
Currently, the price of one share of Resmed stock is $252.50.
How can I analyze the RMD stock price chart for investment decisions?
The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.
Does RMD offer dividends to its shareholders?
Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.85%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Resmed?
Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.